BEMDOM 180 TABLET

Product Description

BEMDOM 180 TABLET
Bempedoic Acid 180 mg

Product Description:

BEMDOM 180 TABLET is a lipid-lowering agent formulated with Bempedoic Acid 180 mg, developed to help manage elevated LDL-C (bad cholesterol) levels in patients with hypercholesterolemia or mixed dyslipidemia. As an ATP citrate lyase (ACL) inhibitor, it offers an effective oral alternative or add-on therapy to statins, especially for patients with statin intolerance or inadequate lipid control.

Key Benefits:

• Helps significantly reduce LDL cholesterol levels

• Suitable as monotherapy or in combination with statins or ezetimibe

• Ideal for patients with familial hypercholesterolemia or high cardiovascular risk

• Well-tolerated with a favorable safety profile

Usage/Application:
Recommended as an adjunct to diet and exercise to lower cholesterol in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH). Commonly used in cardiology, general medicine, and internal medicine settings.

Composition:

• Bempedoic Acid 180 mg

Target Buyers:
Preferred by cardiac medicine wholesalers, hospital pharmacies, lipid management clinics, and bulk pharmaceutical distributors seeking high-demand cholesterol-lowering therapies.

Availability:

Ready for bulk procurement, third-party manufacturing, and distributor collaborations across Indian and global pharmaceutical markets with GMP-certified quality.